587 related articles for article (PubMed ID: 29724627)
1. Graft failure after allogeneic hematopoietic stem cell transplantation.
Ozdemir ZN; Civriz Bozdağ S
Transfus Apher Sci; 2018 Apr; 57(2):163-167. PubMed ID: 29724627
[TBL] [Abstract][Full Text] [Related]
2. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes.
Chen J; Pang A; Zhao Y; Liu L; Ma R; Wei J; Chen X; He Y; Yang D; Zhang R; Zhai W; Ma Q; Jiang E; Han M; Zhou J; Feng S
Hematology; 2022 Dec; 27(1):293-299. PubMed ID: 35192779
[TBL] [Abstract][Full Text] [Related]
3. Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.
Locatelli F; Lucarelli B; Merli P
Expert Opin Pharmacother; 2014 Jan; 15(1):23-36. PubMed ID: 24156789
[TBL] [Abstract][Full Text] [Related]
4. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
Kong Y
Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
[TBL] [Abstract][Full Text] [Related]
5. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
[TBL] [Abstract][Full Text] [Related]
6. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS
Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557
[TBL] [Abstract][Full Text] [Related]
7. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
8. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.
Teltschik HM; Heinzelmann F; Gruhn B; Feuchtinger T; Schlegel P; Schumm M; Kremens B; Müller I; Ebinger M; Schwarze CP; Ottinger H; Zips D; Handgretinger R; Lang P
Br J Haematol; 2016 Oct; 175(1):115-22. PubMed ID: 27341180
[TBL] [Abstract][Full Text] [Related]
9. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
[TBL] [Abstract][Full Text] [Related]
10. [Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Couturier MA; Azarnoush S; Girault S; Hermet E; Masouridi Levrat S; Schmidt A; Michallet M; Etancelin P; Guillaume T; Malard F; Sirvent A; Yakoub-Agha I; Poiré X
Bull Cancer; 2019 Jan; 106(1S):S40-S51. PubMed ID: 30409466
[TBL] [Abstract][Full Text] [Related]
11. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.
Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856
[TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.
Servais S; Beguin Y; Baron F
Expert Opin Emerg Drugs; 2013 Jun; 18(2):173-92. PubMed ID: 23663037
[TBL] [Abstract][Full Text] [Related]
13. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Kharfan-Dabaja MA; Kumar A; Ayala E; Aljurf M; Nishihori T; Marsh R; Burroughs LM; Majhail N; Al-Homsi AS; Al-Kadhimi ZS; Bar M; Bertaina A; Boelens JJ; Champlin R; Chaudhury S; DeFilipp Z; Dholaria B; El-Jawahri A; Fanning S; Fraint E; Gergis U; Giralt S; Hamilton BK; Hashmi SK; Horn B; Inamoto Y; Jacobsohn DA; Jain T; Johnston L; Kanate AS; Kansagra A; Kassim A; Kean LS; Kitko CL; Knight-Perry J; Kurtzberg J; Liu H; MacMillan ML; Mahmoudjafari Z; Mielcarek M; Mohty M; Nagler A; Nemecek E; Olson TS; Oran B; Perales MA; Prockop SE; Pulsipher MA; Pusic I; Riches ML; Rodriguez C; Romee R; Rondon G; Saad A; Shah N; Shaw PJ; Shenoy S; Sierra J; Talano J; Verneris MR; Veys P; Wagner JE; Savani BN; Hamadani M; Carpenter PA
Transplant Cell Ther; 2021 Aug; 27(8):642-649. PubMed ID: 34304802
[TBL] [Abstract][Full Text] [Related]
14. Transplantation for thalassemia major: alternative donors.
Locatelli F; Merli P; Strocchio L
Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
[TBL] [Abstract][Full Text] [Related]
15. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.
Merli P; Caruana I; De Vito R; Strocchio L; Weber G; Del Bufalo F; Buatois V; Montanari P; Cefalo MG; Pitisci A; Algeri M; Galaverna F; Quintarelli C; Cirillo V; Pagliara D; Ferlin W; Ballabio M; De Min C; Locatelli F
Haematologica; 2019 Nov; 104(11):2314-2323. PubMed ID: 30792213
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
Park JH; Lee JH; Lee JH; Park HS; Choi EJ; Kang YA; Kang H; Woo JM; Lee YS; Jeon M; Lee KH
J Korean Med Sci; 2021 Jun; 36(23):e151. PubMed ID: 34128593
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
Hwang YY; Mohty M; Chim CS
Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
[TBL] [Abstract][Full Text] [Related]
20. Salvage allogeneic hematopoietic SCT for primary graft failure in children.
Kato M; Matsumoto K; Suzuki R; Yabe H; Inoue M; Kigasawa H; Inagaki J; Koh K; Hashii Y; Tauchi H; Suminoe A; Kikuta A; Sakamaki H; Kawa K; Kato K; Fukuda T
Bone Marrow Transplant; 2013 Sep; 48(9):1173-8. PubMed ID: 23524639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
